Consonance Capital Partners (CCP) has announced it has closed its second fund at the hard cap of $856 million.

The firm indicated that the new fund — Consonance Private Equity II — will focus on investments in U.S. healthcare companies in the lower and middle markets, consistent with its first fund.

Founded in 2005, CCP pursues investments in lower middle market companies exclusively in the healthcare industry. Based in New York, the firm targets companies that generally have between $20 million and $150 million in revenue.